Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Surgery Physician in Eureka, CA
NPI: 1750352621Primary Practice Location
PROVIDENCE ST JOSEPH HOSPITAL
2700 Dolbeer St, Eureka, CA
Primary Employer
St Joseph Hospital - Eureka
providence.org
HQ Phone
Get M.D. Mary's Phone NumberMobile
Get M.D. Mary's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1982 - 2026
Stanford University School Of Medicine
med.stanford.edu
Medical School
Until 1981
Stanford Health Care-Sponsored Stanford University
Residency • Surgery
1981 - 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 38900Lymph node imaging during surgery | 25 | 26 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 24 | 27 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 24 | 28 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 19 | 19 |
| 5 | 19302Partial removal of breast and underarm lymph nodes | 18 | 18 |
Health information department reorganization resulting from the implementation of optical imaging.
Authors: Mahoney, M. E., Doupnik, A.
Radiation recall reaction with letrozole therapy in breast cancer.
Presentation of the Margaret E. Mahoney Award.
Authors: Mahoney, M.E.
Lead Sponsor: Dr. Susan Love Research Foundation
Intervention / Treatment: OTHER: laboratory biomarker analysis, GENETIC: polymerase chain reaction, OTHER: immunohistochemistry staining method, GENETIC: DNA methylation analysis, GENETIC: fluorescence in situ hybridization, PROCEDURE: therapeutic conventional surgery, PROCEDURE: neoadjuvant therapy, OTHER: immunoenzyme technique, DRUG: pegylated liposomal doxorubicin hydrochloride, PROCEDURE: breast duct lavage, GENETIC: loss of heterozygosity analysis, GENETIC: TdT-mediated dUTP nick end labeling assay
